MYC and leukemia: 25-hydroxycholesterol (25-HC) induced apoptosis in a leukemia model system [19], and 25-HC treatment repressed expression of the proto-oncogene c-myc, an early response gene [20,21] whose product, c-Myc, is critical for the control of cell proliferation and differentiation [22].